4
Changes in Ownership
Passage BIO, Inc. Filed Acc 0001209191-24-000367
SVP, Interim CFO sold 10,672 shares at $0.91 ($9,712)
- SVP, Interim CFO acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Borthwick Kathleen SVP, Interim CFO | 2023-12-31 | Option exercise | +30,000 | 36,608 | D | ||
| Borthwick Kathleen SVP, Interim CFO | 2024-01-02 | Sale | −10,672 | $0.91 | $9,712 | 25,936 | D |
| Derivatives | |||||||
| Borthwick Kathleen SVP, Interim CFO | 2023-12-31 | Option exercise · Restricted Stock Unit | −30,000 | 0 | D | ||
| Open-market sales · 10,672 sh · avg $0.91 · $9,712 | |||||||
Loading xslF345X05/doc4.xml…